Learn about the gut-brain connection in mental health and how targeting serotonin in the gut could revolutionise ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Opens in a new tab or window In patients with severe metabolic dysfunction-associated steatohepatitis (MASH), the investigational drug efruxifermin ... trial of the antidepressant amitriptyline ...

RFK Jr. says antidepressants could cause school shootings and are 'harder to get off' of than heroin. Experts say he's 'way off base.' ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...

Johnson & Johnson JNJ announced that the FDA has approved its supplemental new drug application (sNDA), seeking approval for ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...

Recent studies on antidepressant-treatment response have focused on both aspects of pharmacogenetics research, identifying new candidate genes ... only one-third of drug-treated patients exhibit ...